Christine Walsh

3PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPreventative health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 03, 2021
Phase II trial of cisplatin, gemcitabine and pembrolizumab for platinum-resistant ovarian cancer.

Christine S Walsh, Mitchell Kamrava, Andre Rogatko

|Aug 14, 2020
PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline.

William P Tew, Christina Lacchetti, Annie Ellis

|Jan 10, 2018
Who is at risk after risk reduction?

Christine S Walsh

Pageof 1